Clin2
NCT06265272Possibly a fitRecruiting

PSMA-11 PET/MRI for Liver Cirrhosis

Liver CirrhosisHepatic Cell CarcinomaPortal Hypertension

Treatments studied

Part of Cancer, Digestive system clinical trials.

This study uses a special PET/MRI scan with a tracer called PSMA-11 to look at how liver cirrhosis affects the liver. It may help doctors better understand and monitor the disease.

Summary written for real people, not researchers, by Clin2.

Phase
N/A
Enrollment
45 people
Ages
18 years to 99 years
Study type
Observational

Who can take part

  • You must have been diagnosed with liver cirrhosis (based on imaging, tests, or a biopsy).
  • You cannot be pregnant or breastfeeding.
  • You must not have any condition that makes a PET or MRI unsafe (like metal implants, severe claustrophobia, or allergies).
  • You must not be allergic to gadolinium, the contrast dye used in MRI.
  • Your research radiation in the past year must be low enough that the total for this study stays under 50 mSv.
  • You must weigh less than 300 lbs and have a BMI below 33 to fit in the scanner.

View the official record on ClinicalTrials.gov

Quick eligibility check

Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.

Similar studies

Other trials that look related to this one.

NCT06252610Not yet recruiting
PET/MRI study for primary sclerosing cholangitis (PSC)

This study uses a PET/MRI scan to take detailed pictures of the liver and bile ducts in people with PSC. The goal is to better understand the disease and possibly find new ways to track it.

Charlestown, Massachusetts
NCT06999837Recruiting
PSMA PET/CT scan for liver cancer (HCC)

This study tests a new type of PET/CT scan (called PSMA) that may help doctors see liver cancer (HCC) better. The scan takes detailed images to track how the cancer behaves, which could help choose the best treatment.

Clichy
NCT07352345Not yet recruiting· Early Phase 1
Comparing a new PET scan to MRI for finding liver cancer

This trial uses a special PET scan that targets a protein found in liver cancer cells. It aims to see if this new scan works better than an enhanced MRI to find liver cancer. If you have suspected or confirmed liver cancer, this study might help guide your care.

Wuhan, Hubei
NCT06494696Recruiting
PSMA PET/MRI with MRI for prostate cancer risk

This study tests whether a special scan (PSMA PET/MRI) combined with a standard MRI can better detect prostate cancer. It is for men who have not had a biopsy yet and are suspected of having prostate cancer.

Taoyuan City
NCT06835244Enrolling by invitation
Study of PSMA PET/CT scans for non-prostate cancers

This study looks at how well a special scan (PSMA PET/CT) works for people with cancers other than prostate cancer. If your doctor already scheduled this scan for your care, you may be able to help researchers learn more about its accuracy.

Bologna
NCT07747493Not yet recruiting
PSMA PET/MRI to guide treatment for prostate cancer

This trial uses a special imaging test (PET/MRI) to look at prostate cancer in detail before surgery. The goal is to see if this imaging can help choose the best treatment, possibly sparing healthy tissue.

Toronto, Ontario

Hear when a new Liver Cirrhosis trial opens

We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.